Clinical trial
Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions
NCT00614848 is registered in ClinicalTrials.gov with Medtronic Vascular as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions
- Lead sponsor
- Medtronic Vascular
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2003
- Completion date
- July 31, 2009
- Enrollment
- 1,200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
arterial occlusive diseases, arteriosclerosis, coronary arteriosclerosis, coronary artery disease, coronary disease, heart diseases, ischemia, myocardial ischemia, vascular diseases